List of individual national QUM indicators 2014

Antithrombotic therapy

• 1.1 – Percentage of hospitalised adult patients that are assessed for risk of venous thromboembolism
• 1.2 – Percentage of hospitalised adult patients that receive venous thromboembolism prophylaxis appropriate to their level of risk
• 1.3 – Percentage of patients prescribed enoxaparin whose dosing schedule is appropriate
• 1.4 – Percentage of patients prescribed hospital initiated warfarin whose loading doses are consistent with a drug and therapeutics committee
• 1.5 – Percentage of patients with an INR above 4 whose dosage has been adjusted or reviewed prior to the next warfarin dose
• 1.6 – Percentage of patients with atrial fibrillation that are discharged on oral anticoagulants

Antibiotic therapy

• 2.1 – Percentage of patients undergoing specified surgical procedures that receive an appropriate prophylactic antibiotic regimen
• 2.2 – Percentage of prescriptions for restricted antibiotics that are concordant with drug and therapeutics committee approved criteria
• 2.3 – Percentage of patients prescribed hospital initiated warfarin whose
• 2.4 – Percentage of adult patients with community acquired pneumonia
• 2.5 – Percentage of patients presenting with community acquired pneumonia

Medication ordering

• 3.1 – Percentage of patients whose current medicines are documented and reconciled at admission
• 3.2 – Percentage of patients whose known adverse drug reactions are documented on the current medication chart
• 3.3 – Percentage of medication orders that include error-prone abbreviations
• 3.4 – Percentage of paediatric medication orders that include the correct dose per kilogram (or body surface area) AND an effective and safe total dose
• 3.5 – Percentage of medication orders for intermittent therapy that are prescribed safely
• 3.6 – Percentage of patients receiving cytotoxic chemotherapy whose treatment is guided by a hospital approved chemotherapy treatment protocol

Pain management

• 4.1 – Percentage of postoperative patients whose pain intensity is documented using an appropriate validated assessment tool
• 4.2 – Percentage of postoperative patients that are given a written pain management plan at discharge AND a copy is communicated to the primary care clinician

Continuity of care

• 5.1 – Percentage of patients with acute coronary syndrome that are prescribed appropriate medicines at discharge
• 5.2 – Percentage of patients with systolic heart failure that are prescribed appropriate medicines at discharge
• 5.3 – ercentage of discharge summaries that include medication therapy changes and explanations for changes
• 5.4 – Percentage of patients on warfarin that receive written information regarding warfarin management prior to discharge
• 5.5 – Percentage of patients with a new adverse drug reaction (ADR) that are given written ADR information at discharge AND a copy is communicated to the primary care clinician
• 5.6 – Percentage of patients with asthma that are given a written asthma action plan at discharge AND a copy is communicated to the primary care clinician
• 5.7 – Percentage of patients receiving sedatives at discharge that were not taking them at admission
• 5.8 – Percentage of patients whose discharge summaries contain a current, accurate and comprehensive list of medicines
• 5.9 – Percentage of patients who receive a current, accurate and comprehensive medication list at the time of hospital discharge

Hospital-wide medication management policies

• 6.1 – Percentage of medication storage areas outside pharmacy where potassium ampoules are available
• 6.2 – Percentage of patients that are reviewed by a clinical pharmacist within one day of admission
• 6.3 – Percentage of parenteral opioid dosage units that are pethidine
• 6.4 – Percentage of submissions for formulary listing of new chemical entities for which the drug and therapeutics committee has access to adequate information for appropriate decision making

Acute mental health care

• 7.1 – Percentage of as required (PRN) psychotropic medication orders with documented indication, dose (or dose range), frequency and maximum daily dose specified
• 7.2 – Percentage of patients taking lithium who receive appropriate monitoring during their inpatient episod
• 7.3 – Percentage of patients who receive written and verbal information on regular psychotropic medicines initiated during their admission
• 7.4 – Percentage of patients taking antipsychotic medicines who receive appropriate monitoring for the development of metabolic side effects
• 7.5 – Percentage of patients prescribed two or more regular antipsychotic medicines at hospital discharge